Shikimic acid

Shikimic acid
Product Name Shikimic acid
CAS No.: 138-59-0
Catalog No.: CFN99436
Molecular Formula: C7H10O5
Molecular Weight: 174.2 g/mol
Purity: >=98%
Type of Compound: Miscellaneous
Physical Desc.: Powder
Targets: ROS | NF-kB | JNK | Bcl-2/Bax | Nrf2 | SAPK | Akt
Source: The fruits of Illicium verum.
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
Price: $30/20mg
Shikimic acid(Shikimate), more commonly known as its anionic form shikimate, is an important biochemical intermediate in plants and microorganisms, has great potential for the design and synthesis of enzyme inhibitors. It reversed the H2O2 induced oxidative damage in hepatocytes, probably through the inhibition of NF-κB, with the activation of PI3K/Akt/Nrf2 pathway and reduction of apoptosis by interfering the SAPK/JNK/Bax pathway; it also profoundly inhibited pancreatic lipase activity by 66%, thus providing another valuable therapeutic aspect for treating diet induced obesity in humans.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Antioxidants (Basel).2022, 11(1):171.
  • J Appl Biol Chem.2022, 65(4):pp.463-469.
  • J Ethnopharmacol.2020, 269:113752.
  • J Control Release.2021, 336:159-168.
  • Food Chem.2022, 378:131975.
  • Plants (Basel).2021, 10(4):702.
  • Industrial Crops and Products2022, 188:115638
  • Phytomedicine.2020, 153440.
  • Food Funct.2022, 13(13):6923-6933.
  • J Cell Mol Med.2023, jcmm.18071.
  • Deoxynojirimycin hydrochloride

    Catalog No: CFN90484
    CAS No: 73285-50-4
    Price: Inquiry(manager@chemfaces.com)
    vibo-Quercitol

    Catalog No: CFN98778
    CAS No: 488-76-6
    Price: $218/20mg
    Inositol

    Catalog No: CFN91718
    CAS No: 87-89-8
    Price: $30/20mg
    (E)-1-methoxy-2-O-(p-coumaroyl)-myo-inositol

    Catalog No: CFN95609
    CAS No: 1391715-18-6
    Price: $318/20mg
    D-Pinitol

    Catalog No: CFN99044
    CAS No: 10284-63-6
    Price: $40/20mg
    L-Quebrachitol

    Catalog No: CFN90586
    CAS No: 642-38-6
    Price: Inquiry(manager@chemfaces.com)
    Conduritol A

    Catalog No: CFN98868
    CAS No: 526-87-4
    Price: $258/10mg
    D-(-)-Quinic acid

    Catalog No: CFN99930
    CAS No: 77-95-2
    Price: $30/20mg
    Shikimic acid

    Catalog No: CFN99436
    CAS No: 138-59-0
    Price: $30/20mg
    3,4-O-Isopropylidene shikimic acid

    Catalog No: CFN99852
    CAS No: 183075-03-8
    Price: Inquiry(manager@chemfaces.com)
    Antonie Van Leeuwenhoek. 2015 Feb;107(2):419-31.
    Shikimic acid, a base compound for the formulation of swine/avian flu drug: statistical optimization, fed-batch and scale up studies along with its application as an antibacterial agent.[Pubmed: 25563634]
    The sudden outbreak of swine flu has increased the global demand of Shikimic acid which is an industrially interesting compound, as it is used as a key starting material for the synthesis of a neuraminidase inhibitor Tamiflu(®), for the treatment of antiviral infections such as swine flu.
    METHODS AND RESULTS:
    Statistical optimization and evaluation of medium components for the production of Shikimic acid by Citrobacter freundii is addressed in the present investigation. Plackett-Burman design was applied for the screening of the most significant variables affecting Shikimic acid production, where glucose, asparagine, KH2PO4, CaCO3 and agitation rate were the most significant factors. Response surface methodology was also employed to study the interaction among the most significant variables through which Shikimic acid production increased to 12.76 g/L. Further, fed-batch studies resulted in the production of 22.32 g/L of Shikimic acid. The scalability of the process was also confirmed by running 14 L bioreactor (7.5 L production medium) where 20.12 g/L of Shikimic acid was produced.
    CONCLUSIONS:
    In addition the antibacterial activity of the Shikimic acid produced was analysed against four Gram positive and four Gram negative bacteria and it was found to have a greater inhibition effect against the Gram negative bacteria.
    Bioresour Technol. 2013 Sep;144:675-9.
    An interactive study of influential parameters for shikimic acid production using statistical approach, scale up and its inhibitory action on different lipases.[Pubmed: 23871288]
    Shikimic acid is the promising candidate as a building block for the industrial synthesis of drug Tamiflu used for the treatment of Swine flu. The fermentative production process using microbes present an excellent and even more sustainable alternative to the traditional plants based extraction methods.
    CONCLUSIONS:
    In the present study, the fermentative production of Shikimic acid by Citrobacter freundii GR-21 (KC466031) was optimized by process engineering using a statistical modeling approach and a maximum amount of 16.78 g L(-1) was achieved. The process was also scaled up to 14L bioreactor to validate the production of Shikimic acid. Further, the potential of anti-enzymatic nature of purified Shikimic acid was evaluated for different lipases wherein, Shikimic acid inhibited the hydrolysis of triglycerides by 55-60%.
    CONCLUSIONS:
    Shikimic acid also profoundly inhibited pancreatic lipase activity by 66%, thus providing another valuable therapeutic aspect for treating diet induced obesity in humans.
    J Ethnopharmacol. 2014 Aug 8;155(1):132-46.
    Protective effect of coconut water concentrate and its active component shikimic acid against hydroperoxide mediated oxidative stress through suppression of NF-κB and activation of Nrf2 pathway.[Pubmed: 24835026]
    Conventionally coconut water has been used as an 'excellent hydrating' drink that maintain the electrolyte balance and help in treating diverse ailments related to oxidative stress including liver function. The present study was aimed to elucidate whether and how the coconut water concentrate (CWC) and its major active phytoconstituent Shikimic acid (SA) can effectively protect murine hepatocytes from the deleterious effect of hydroperoxide-mediated oxidative stress.
    METHODS AND RESULTS:
    Bioactivity guided fractionation of CWC resulted in the isolation of a couple of known compounds. Freshly isolated murine hepatocytes were exposed to hydrogen peroxide (H2O2) (1 and 3mM) in the presence or absence of CWC (200 and 400 μg/ml) and SA (40 μM) for the determination of antioxidative, DNA protective, cellular ROS level by modern methods, including immunoblot and flowcytometry to find out the possible mechanism of action. Pre-treatment of hepatocyte with CWC and SA showed significant prevention of H2O2-induced intracellular ROS generation, nuclear DNA damage along with the formation of hepatic TBARS and cellular nitrite. Further, the H2O2 induced cell death was arrested in the presence of CWC through the inhibition of CDC42 mediated SAPK/JNK pathways and activation of other molecules of apoptotic pathways, including Bax and caspase3. Moreover, CWC and SA help in maintaining the GSH level and endogenous antioxidants like Mn-SOD, to support intracellular defense mechanisms, probably through the transcriptional activation of Nrf2; and inhibition of nuclear translocation of NF-κB.
    CONCLUSIONS:
    CWC and its active components SA reversed the H2O2 induced oxidative damage in hepatocytes, probably through the inhibition of NF-κB, with the activation of PI3K/Akt/Nrf2 pathway and reduction of apoptosis by interfering the SAPK/JNK/Bax pathway.
    (1S,2S)-threo-Honokitriol

    Catalog No: CFN95076
    CAS No: 1099687-80-5
    Price: $413/5mg
    Quercetin 3-Caffeylrobinobioside

    Catalog No: CFN95151
    CAS No: 957110-26-8
    Price: $413/5mg
    Isovalerylshikonin

    Catalog No: CFN95222
    CAS No: 52387-14-1
    Price: $318/10mg
    cis-Aegineoside

    Catalog No: CFN95295
    CAS No: N/A
    Price: $413/5mg
    13(S)-Hydroxyoctadeca-9(Z),11(E)-dienoic acid (13-HODE)

    Catalog No: CFN95307
    CAS No: 18104-45-5
    Price: $318/10mg
    4'-O-Methyllucenin II (Diosmetin 6,8-di-C-glucoside)

    Catalog No: CFN95344
    CAS No: 98813-28-6
    Price: $318/10mg
    Dioscoreside C

    Catalog No: CFN95345
    CAS No: 344912-80-7
    Price: $318/5mg
    Kaempferol 3,4'-di-O-glucoside

    Catalog No: CFN95357
    CAS No: 71939-16-7
    Price: $318/5mg
    11beta,13-Dihydrolactucin

    Catalog No: CFN95433
    CAS No: 83117-63-9
    Price: $318/10mg
    Methyl nomilinate

    Catalog No: CFN95576
    CAS No: 77887-51-5
    Price: $318/5mg